Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #8 on Senti Biosciences Inc (SNTI)
TheFinalCD
10/04/23 4:50 AM
#9 RE: jondoeuk #8
$SNTI Senti Biosciences has received a Notice of Allowance for its US patent application 17/338,528 titled "CHIMERIC RECEPTORS AND METHODS OF USE THEREOF (FOR TREATMENT OF ACUTE MYELOID LEUKEMIA)". https://t.co/YAXik6A33A pic.twitter.com/ExNJ0YYhum— PatentGrants (@PatentGrants) October 3, 2023
$SNTI Senti Biosciences has received a Notice of Allowance for its US patent application 17/338,528 titled "CHIMERIC RECEPTORS AND METHODS OF USE THEREOF (FOR TREATMENT OF ACUTE MYELOID LEUKEMIA)". https://t.co/YAXik6A33A pic.twitter.com/ExNJ0YYhum
TOP WATCH $SNTI on REVERSAL WATCH PATEN T NEWS FOR LEUKIMIA$6 PT— Thinking (@PromotingLife1) October 4, 2023
TOP WATCH $SNTI on REVERSAL WATCH PATEN T NEWS FOR LEUKIMIA$6 PT